Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway

Nature Neuroscience volume 17, pages 27–29 (2014)Cite this article

Subjects

Abstract

Mechanisms controlling release of brain-derived neurotrophic factor (BDNF) in the mesolimbic dopamine reward pathway remain unknown. We report that phasic optogenetic activation of this pathway increases BDNF amounts in the nucleus accumbens (NAc) of socially stressed mice but not of stress-naive mice. This stress gating of BDNF signaling is mediated by corticotrophin-releasing factor (CRF) acting in the NAc. These results unravel a stress context–detecting function of the brain's mesolimbic circuit.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Optogenetic phasic activation of VTA-NAc pathway increases BDNF amounts in the NAc of socially stressed mice but not of stress-naive mice.
Figure 2: BDNF is necessary for the optogenetically induced susceptible phenotype.
Figure 3: CRF is required for phasic firing induced increase in the NAc BDNF in the context of stress.

Similar content being viewed by others

References

  1. Park, H. & Poo, M.M. Nat. Rev. Neurosci. 14, 7–23 (2013).

    Article  CAS  Google Scholar 

  2. Nestler, E.J. et al. Neuron 34, 13–25 (2002).

    Article  CAS  Google Scholar 

  3. Nestler, E.J. & Carlezon, W.A. Jr. Biol. Psychiatry 59, 1151–1159 (2006).

    Article  CAS  Google Scholar 

  4. Berton, O. et al. Science 311, 864–868 (2006).

    Article  CAS  Google Scholar 

  5. Krishnan, V. et al. Cell 131, 391–404 (2007).

    Article  CAS  Google Scholar 

  6. Grace, A.A. et al. Trends Neurosci. 30, 220–227 (2007).

    Article  CAS  Google Scholar 

  7. Lobo, M.K. et al. Science 330, 385–390 (2010).

    Article  CAS  Google Scholar 

  8. Lammel, S. et al. Neuron 70, 855–862 (2011).

    Article  CAS  Google Scholar 

  9. Matsuda, N. et al. J. Neurosci. 29, 14185–14198 (2009).

    Article  CAS  Google Scholar 

  10. Tsai, H.C. et al. Science 324, 1080–1084 (2009).

    Article  CAS  Google Scholar 

  11. Cao, J.L. et al. J. Neurosci. 30, 16453–16458 (2010).

    Article  CAS  Google Scholar 

  12. Koo, J.W. et al. Science 338, 124–128 (2012).

    Article  CAS  Google Scholar 

  13. Chaudhury, D. et al. Nature 493, 532–536 (2013).

    Article  CAS  Google Scholar 

  14. Koob, G.F. et al. Neurosci. Biobehav. Rev. 27, 739–749 (2004).

    Article  CAS  Google Scholar 

  15. Tye, K.M. et al. Nature 493, 537–541 (2013).

    Article  CAS  Google Scholar 

  16. Wanat, M.J., Bonci, A. & Phillips, P.E. Nat. Neurosci. 16, 383–385 (2013).

    Article  CAS  Google Scholar 

  17. Cazorla, M. et al. J. Clin. Invest. 121, 1846–1857 (2011).

    Article  CAS  Google Scholar 

  18. Lemos, J.C. et al. Nature 490, 402–406 (2013).

    Article  Google Scholar 

  19. Pecina, S., Schulkin, J. & Berridge, K.C. BMC Biol. 4, 8 (2006).

    Article  Google Scholar 

  20. Schnitzer, M.J. Nature 416, 683 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institute of Mental Health (R01 MH092306: D.C. and M.-H.H.), Johnson & Johnson/International Mental Health Research Organization Rising Star Translational Research Award (M.-H.H.) and National Research Service Awards (F31 MH095425: J.J.W.; F32 MH096464: A.K.F.).

Author information

Authors and Affiliations

  1. Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    Jessica J Walsh, Allyson K Friedman, Stacy M Ku, Barbara Juarez, Veronica L Burnham, Dipesh Chaudhury, Eric J Nestler & Ming-Hu Han

  2. Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA

    Jessica J Walsh, Haosheng Sun, Elizabeth A Heller, Stacy M Ku, Barbara Juarez, Veronica L Burnham, Michelle S Mazei-Robison, Deveroux Ferguson, Sam A Golden, Ja Wook Koo, Daniel J Christoffel, Scott J Russo, Eric J Nestler & Ming-Hu Han

  3. Laboratory of Molecular Genetics, Howard Hughes Medical Institute, Rockefeller University, New York, New York, USA

    Lisa Pomeranz & Jeffrey M Friedman

Authors
  1. Jessica J Walsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allyson K Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haosheng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth A Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stacy M Ku
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Barbara Juarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Veronica L Burnham
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michelle S Mazei-Robison
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Deveroux Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sam A Golden
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ja Wook Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Dipesh Chaudhury
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Daniel J Christoffel
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Lisa Pomeranz
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jeffrey M Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Scott J Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Eric J Nestler
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Ming-Hu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.J.W., A.K.F., H.S., E.A.H., S.M.K, B.J., V.L.B., M.S.M.-R., D.F., S.A.G., J.W.K., D.C. and D.J.C. collected and analyzed data. L.P., J.M.F., S.J.R. and E.J.N. generated and provided viral vectors and Thcre and BdnfloxP/loxP mice. J.J.W., E.J.N. and M.-H.H. designed the study and wrote the manuscript.

Corresponding author

Correspondence to Ming-Hu Han.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Viral placement and immunohistochemical validation.

(a) Schematic adapted from Allen Brain Atlas illustrating validation of NAc injection cite (scale 50 μm). Accurate injection sites were confirmed in all animals. (b) Schematic adapted from the Allen Brain Atlas showing VTA and confocal images showing co-expression of AAV-DIO-ChR2-eYFP and TH-positive cells in VTA that specifically project to NAc (scale 50 μm).

Supplementary Figure 2 Experimental timeline, viral injection schematic and behavioral sample traces.

(a) Schematic of PRV-Cre infused into NAc, AAV-DIO-ChR2-eYFP infused into VTA, and ferrule implantation into VTA with experimental timeline below. (b) Representative image of real-time tracing of animals during the social interaction test with optical stimulation. Left panel shows an eYFP control animal and right panel shows an animal that received phasic stimulation with ChR2.

Supplementary Figure 3 Subthreshold social stress alone does not induce social avoidant behavior and changes in NAc BDNF levels.

(a) Social interaction times of stress-naïve and subthreshold defeated animals (unpaired t-test, t8 = 0.125, P = 0.9004, n = 5,5 mice/group). (b) Quantification of NAc BDNF levels following subthreshold social (unpaired t-test, t8 = 0.253, P = 0.8069; n = 5,5 mice/group). (c) Full blot of Supplemental Figure 3b. Data presented as mean ± s.e.m.

Source data

Supplementary Figure 4 Schematic and validation of the retrograde AAV2/5-DIO-ChR2-eYFP in Thcre mice.

(a) Schematic of ChR2 into NAc and ferrule implantation into VTA of Thcre mice and timeline. (b) Confocal image showing co-expression of AAV2/5-DIO-ChR2-eYFP and TH-positive cells in VTA to NAc cells of Thcre (scale 25 μm). (c) Phasic light stimulation induced spiking in VTA-NAc DA neurons expressing AAV2/5.

Supplementary Figure 5 Timeline of experiments with stress-naive mice.

(a) Experimental timeline of stress-naïve mice with optical stimulation during social interaction. (b) Timeline of stress-naïve mice with five days of repeated optical stimulation (20 min/day).

Supplementary Figure 6 Schematics of experiments.

(a) Schematic and timeline of VTA-NAc neurons with cannula implantation into NAc for infusion of TrkB inhibitor, ANA-12, 1 h prior to behavior with stimulation. (b) Schematic and timeline showing targeting of VTA-NAc cells in BdnfloxP/loxP and controls.

Supplementary Figure 7 Intra-NAc CRF antagonist infusion.

(a) Timeline of animals that received intra-NAc CRF antagonist infusions. (b) Social interaction times of phasic stimulation of VTA-NAc neurons infected with AAV-DIO-eYFP (unpaired t-test, t10 = 0.091, P = 0.9291, n = 6,6 mice/group) and (c) BDNF level quantification (unpaired t-test, t8 = 0.38, P = 0.7112, n = 5,5 mice/group) after intra-NAc CRF antagonist infusion compared to vehicle. (d) Full blot of supplemental Figure 7c. Data presented as mean ± s.e.m.

Source data

Supplementary Figure 8 Intra-NAc infusions of CRF in stress-naive animals.

(a) Schematic and timeline of stress-naïve animals that received intra-NAc CRF infusions. (b) Social interaction times (F2,15 = 0.37, P = 0.7001, n = 6,6,6 mice/group) and (c) BDNF level quantification (F2,15 = 0.14, P = 0.8665, n = 6,6,6 mice/group) of animals that received phasic stimulation of VTA-NAc neurons infected with AAV-DIO-eYFP following intra-NAc CRF infusion or in animals that received tonic stimulation of VTA-NAc neurons infected with AAV-DIO-ChR2-eYFP compared to control. Data presented as mean ± s.e.m.

Source data

Supplementary Figure 9 Schematics of proposed mechanism of BDNF upregulation in the VTA-NAc circuit in the context of social stress.

(a) Schematic showing that stress gates the up-regulation of BDNF signaling in NAc by working together with phasic firing of VTA DA neurons that project to NAc as well as CRF actions in NAc, which may be both pre- and postsynaptic. (b) Schematic illustrating proposed interactions of BDNF and CRF in promoting stress susceptibility. Our data suggest that stress-induced CRF signaling in NAc activates its receptors located presynaptically on terminals of VTA DA neurons and works together with arriving phasic spikes from these DA neurons to release BDNF. BDNF then activates TrkB receptors located on NAc medium spiny neurons to promote susceptibility. Direct postsynaptic actions of CRF on these medium spiny neurons might also contribute to susceptibility.

Supplementary Figure 10 Full blots for all experiments.

(a) Figure 1b. (b) Figure 1d. (c) Figure 1f. (d) Figure 1h. (e) Figure 2b. (f) Figure 2d. (g) Figure 3b. (h) Figure 3d. (i) Figure 3f.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10 (PDF 6868 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walsh, J., Friedman, A., Sun, H. et al. Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway. Nat Neurosci 17, 27–29 (2014). https://doi.org/10.1038/nn.3591

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.3591

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing